Document is current

Article History

Received: 25 August 2021

Accepted: 22 November 2021

First Online: 11 December 2021

Declarations

:

: Diagnostics, assessments in VR, HRV recordings or the gSST are not expected to produce negative side effects beyond increased awareness. Participants will be remunerated for their expenditure of time in the App based study 1 and study 2. Providing CBT-E and INTER-E interventions for LOC adapted to the needs of youth should produce positive effects (the pilot BEAT trial had strong within subject effects on LOC episodes, ED pathology and mood, and 81% of participants reported at the end of the treatment to have no LOC anymore or that the consumed food amount during a LOC episode decreased). Upcoming problems are monitored and in case of difficulties, support in coping is given by the therapists under supervision of SM and emergency contacts are provided. Collaborators will be trained to handle subject burden of participating youth together with SM. This study has been approved by the ethics committee of the canton of Berne (2018-00230). All participants will be asked for written informed consent before inclusion in the study. The i-BEAT study is registered at the German Clinical Trials Register (DRKS00023706). The participants age ranges between 14 and 24 years. According to swiss law, youth, even below the age of 14 years has the right of non-information of their legal guardians with respect to a participation in a psychotherapeutic treatment. All participants under the age of 18 years are therefore invited but not obliged to inform the legal guardians about their participation in i-BEAT and a respective parents’ information sheet can be provided. Therefore, informed consents are signed either by participating youth alone or together with their legal guardians.

: Not applicable.

: There are no competing interests.